Glucotrack (GCTK) Income towards Parent Company (2010 - 2025)
Glucotrack (GCTK) posted Income towards Parent Company of -$3.4 million for Q4 2025, up 21.37% on a QoQ basis from -$4.3 million in Q3 2025, and up 11.86% year-over-year from -$3.1 million in Q4 2024.
Glucotrack (GCTK) Income towards Parent Company (2010 - 2025) Analysis & Trends
Glucotrack's Income towards Parent Company history runs 15 years deep, the most recent figure standing at -$3.4 million for Q4 2025.
- Quarterly Income towards Parent Company rose 11.86% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$16.1 million (down 9.47% YoY) and the FY2025 annual result came in at -$16.1 million, down 10.47% from the prior year.
- Income towards Parent Company was -$3.4 million for Q4 2025 at Glucotrack, up from -$4.3 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$838000.0 in Q3 2021 and bottomed at -$4.9 million in Q2 2025.
- A 5-year average of -$2.3 million and a median of -$1.9 million in 2021 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2021 — Income towards Parent Company increased 20.08% — and 2024, when it tumbled 287.7%.
- Glucotrack's Income towards Parent Company stood at -$1.5 million in 2021, then grew by 16.86% to -$1.3 million in 2022, then slumped by 88.58% to -$2.4 million in 2023, then plunged by 59.83% to -$3.9 million in 2024, then climbed by 11.86% to -$3.4 million in 2025.
- Business Quant data shows GCTK's Income towards Parent Company at -$3.4 million in Q4 2025, -$4.3 million in Q3 2025, and -$4.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Glucotrack | 186,390.31 | -7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.42 Mn |
| Sep 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -3.50 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -3.26 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Mar 31, 2024 | -3.04 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -930,000.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -1.55 Mn |
| Sep 30, 2021 | -838,000.00 |
| Jun 30, 2021 | -981,000.00 |
| Mar 31, 2021 | -910,000.00 |